According to researchers from University of the Philippines Manila who are conducting the clinical trial for the use of lagundi as herbal medicine in the management of mild COVID-19 cases, the plant brings “symptomatic relief” to patients without co-morbidities. Studies on the use of tawa-tawa as herbal supplement also yielded positive results.

A 24-year-old doctor and coconut processing company executive has developed a combined virgin coconut oil (VCO) and lagundi mouth and nasal spray formula that can be a potent protection against – if not potential cure – for COVID-19.

Dr. Sterling Tiu, company doctor at his family’s coconut processing business Tropicana Food Products Inc. based in San Pablo City, Laguna, said that the combination of lagundi and VCO addresses both the cough symptoms and viral replication issues in COVID-19 cases.

The Department of Science and Technology-Philippine Council for Health Research and Development (DOST-PCHRD), University of The Philippines-Manila (UPM), and Fondazione Italiana Fegato (FIF) have signed a memorandum of understanding (MOU) seeking to develop and promote scientific and technological cooperation on translational hetapology through joint research and development, grant of scholarships and research fellowships, and exchange of scientists, experts and researchers for studies, and training.

The UP-PGH clinical trials on VCO had been given the green light by the Food and Drug Administration (FDA) in June last year at the height of the pandemic lockdowns in the country. Recruitment and enrollment of participants, however, started only last November.

The R&D study is one of four funded by the DOST to back up claims of the medicinal benefits of VCO especially in curing COVID-19.